ISTA says daily Xibrom eye drops met goal in study |  |
|
Posted by Mary Canady August 26th, 2009 .
| |
| No Comments |
ISTA Pharmaceuticals Inc. on Wednesday reported successful late-stage clinical trial results for Xibrom QD, a new once-per-day eye drug.
See other entries categorized in News, San Diego Union Tribune, Syndication.
Print This Post
.
Subscribe by RSS or email. Connect with San Diego Biotech professionals by joining the SDBN and attending our next event.
Print This Post
.
Subscribe by RSS or email. Connect with San Diego Biotech professionals by joining the SDBN and attending our next event.
